Eli Lilly and Co. CEO John Lechleiter said during a speech today in Washington that he opposes the public-plan option at the center of President Barack Obama’s health care reform principles. He also warned that the “comparative-effectiveness” research of medical treatments, which received vast funding in Obama’s February stimulus bill, could go wrong if it’s […]
Eli Lilly and Co. CEO John Lechleiter said during a speech today in Washington, D.C., that he opposes the public-plan option at the center of President Barack Obama’s health care reform principles. He also warned that the “comparative-effectiveness” research of medical treatments, which received vast funding in Obama’s February stimulus bill, could go wrong if […]
Dr. Hamburger can no longer blame Zyprexa for making you fat. At least he can’t as part of lawsuits brought by patients against Zyprexa’s maker, Indianapolis-based Eli Lilly and Co. Zyprexa treats schizophrenia and bipolar disorder. Federal Judge Jack B. Weinstein in Brooklyn, N.Y., yesterday decided to exclude the expert testimony of Dr. Stephen Hamburger, […]
Top executives at Muncie-based Cardinal Health System are heading out the door as the hospital continues its integration with Indianapolis-based Clarian Health. Three executives will retire by the end of the May, Cardinal announced today, and CEO Kelly Stanley will retire at year’s end. Also, Stanley’s assistant, Karen Swank, will retire at the end of […]
Dr. Hamburger can no longer blame Zyprexa for making you fat. Normal 0 false false false MicrosoftInternetExplorer4 At least he can’t as part of lawsuits brought by patients against Zyprexa’s maker, Indianapolis-based Eli Lilly and Co. Zyprexa treats schizophrenia and bipolar disorder. Federal Judge Jack B. Weinstein in Brooklyn, N.Y., yesterday decided to exclude the […]
With more people out of work and without health insurance, you’d expect that the county-owned Wishard Health Services, whose mission is to treat the poor and indigent, would be flooded. Well, it is, but not any more than usual. Occupancy at its hospital in downtown Indianapolis was 98 percent before the recession and is still […]
Conseco Inc. shareholders have expressed their dissatisfaction with the company’s recent performance by electing a dissident shareholder to the board of directors. Keith Long, a vocal critic of the company’s board, won a majority of votes cast, according to preliminary results announced this morning at Conseco’s annual meeting in Carmel. Exact vote totals were not […]
Normal 0 false false false MicrosoftInternetExplorer4 Conseco Inc. shareholders have expressed their dissatisfaction with the company’s recent performance by electing a dissident shareholder to the board of directors. Keith Long, a vocal critic of the company’s board, won a majority of votes cast, according to preliminary results announced this morning at Conseco’s annual meeting […]
Shares of Conseco Inc. rose as much as 30 percent this morning after the company reported its first quarterly profit in three years. The Carmel-based owner of life and health insurance companies turned a profit of $24.5 million, or 13 cents per share, in the three months ended March 31. In the same quarter a […]
Financial reports trickling in from Indianapolis’ major hospitals show why the city’s health care building boom ground to
a near halt this year. It ran into a wall of investment losses.
Specialist physicians, who have traditionally been fiercely independent, are more and more coming on as employees of hospitals.
An activist shareholder vying to become a director of Conseco Inc. says the insurance company’s board "completely misjudged"
the risks it faced when it emerged from bankruptcy in 2003 and hasn’t recovered since. Now an independent shareholder advisory firm is siding with him.
An activist shareholder vying to become a director of Conseco Inc. says the insurance company’s board “completely misjudged” the risks it faced when it emerged from bankruptcy in 2003 and hasn’t recovered since. Now an independent shareholder advisory firm is siding with him. “The board is blindly pushing forward into risky waters with limited view […]
Amid the aroma of its lobby coffee shop and soothing tones of its player piano, the Indiana Heart Hospital sits at the center of significant changes in how Indianapolis’ hospitals and doctors do business. The 56-bed facility in Castleton was launched in 2003 as a forprofit venture between Community Health Network and its cardiovascular physicians. […]
Financial reports trickling in from Indianapolis’ major hospitals show why the city’s health care building boom ground to a near halt this year. It ran into a wall of investment losses. A case in point: Indianapolisbased Clarian Health suffered a whopping $633 million in losses on its investments and interest-rate swaps last year. That wiped […]
The cost of nursing home care in Indianapolis is rising faster than in the rest of the country, according to an annual survey of long-term-care costs by Virginia-based Genworth Financial. Residents in and around Indianapolis pay nearly $78,700 per year for a private room in a nursing home. That rate has been rising at 7 […]
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year,
Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch on.
Compared with some of his pharmaceutical CEO peers these days, John Lechleiter has his company on a diet. Instead of using a mega-merger to bulk up before the famine that patent expirations will bring on the industry next year, Lechleiter has Eli Lilly and Co. burning management fat while looking for smaller companies to munch […]
Venture capital is flowing a bit more to Indiana and Midwest life sciences companies, according to data released this week. But it’s still nowhere near the record levels of two years ago. Four Indiana firms attracted nearly $9 million in the first three months of 2009, up from just one firm that attracted $6.25 million […]
Dr. David S. Wilkes will succeed Dr. Ora Pescovitz as the Indiana University School of Medicine’s executive associate dean of research affairs, the school announced this morning. Wilkes, a professor of biochemistry, molecular biology, microbiology and immunology, is also the co-founder of ImmuneWorks Inc., a biotechnology company based in Indianapolis. Wilkes’ research specialty is lung-transplant […]
